Login / Signup
Cost-effectiveness of nonavalent HPV vaccination in the Netherlands.
Cody Palmer
Christiaan Dolk
Ugne Sabale
Wei Wang
Kunal Saxena
Published in:
Expert review of vaccines (2024)
Our analyses predict that transitioning from a 2vHPV- to a 9vHPV-based vaccination strategy would be cost-effective in the Netherlands.
Keyphrases
</>
high grade